PMID- 36987580 OWN - NLM STAT- MEDLINE DCOM- 20230608 LR - 20230608 IS - 1097-0010 (Electronic) IS - 0022-5142 (Linking) VI - 103 IP - 10 DP - 2023 Aug 15 TI - Fructo-oligofructose ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions and psychiatric comorbidities in mice. PG - 5004-5018 LID - 10.1002/jsfa.12582 [doi] AB - BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by pruritus and eczema lesions and psychiatric comorbidities. The gut-brain-skin axis plays a pivotal role during AD development, which might suggest a novel therapeutic strategy for AD. The present study aims to uncover the protective effects and underlying mechanisms of fructo-oligofructose (FOS), a type of prebiotic, on AD-like skin manifestations and comorbid anxiety and depression in AD mice. RESULTS: Female Kunming mice were treated topically with 2,4-dinitrofluorobenzene (DNFB) to induce AD-like symptoms and FOS was administered daily for 14 days. The results showed that FOS could alleviate AD-like skin lesions markedly as evidenced by dramatic decreases in severity score, scratching bouts, the levels of immunoglobulin E (IgE) and T helper 1(Th1)/Th2-related cytokines, and the infiltration of inflammatory cells and mast cells to the dermal tissues. The comorbid anxiety and depressive-like behaviors, estimated by the forced swimming test (FST), the tail-suspension test (TST), the open-field test (OFT), and the zero maze test (ZMT) in AD mice, were significantly attenuated by FOS. Fructo-oligofructose significantly upregulated brain neurotransmitters levels of 5-hydroxytryptamine (5-HT) and dopamine (DA). Furthermore, FOS treatment increased the relative abundance of gut microbiota, such as Prevotella and Lactobacillus and the concentrations of short-chain fatty acids (SCFAs), especially acetate and iso-butyrate in the feces of AD mice. The correlation analysis indicated that the reshaped gut microbiome composition and enhanced SCFAs formation are associated with skin inflammation and behavioral alteration. CONCLUSION: Collectively, these data identify FOS as a promising microbiota-targeted treatment for AD-like skin inflammation and comorbid anxiety and depressive-like behaviors. (c) 2023 Society of Chemical Industry. CI - (c) 2023 Society of Chemical Industry. FAU - Chen, Shaoze AU - Chen S AUID- ORCID: 0000-0001-9174-6737 AD - School of Medicine, Jianghan University, Wuhan, China. FAU - Tang, Liu AU - Tang L AUID- ORCID: 0000-0003-1599-7061 AD - Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China. FAU - Nie, Tingting AU - Nie T AD - School of Medicine, Jianghan University, Wuhan, China. FAU - Fang, Mingyu AU - Fang M AD - School of Medicine, Jianghan University, Wuhan, China. FAU - Cao, Xiaoqin AU - Cao X AD - School of Medicine, Jianghan University, Wuhan, China. LA - eng GR - 08210154/the Jianghan University 2021 University Research Program/ GR - 2042022kf1077/the Fundamental Research Funds for the Central Universities/ PT - Journal Article DEP - 20230412 PL - England TA - J Sci Food Agric JT - Journal of the science of food and agriculture JID - 0376334 RN - D241E059U6 (Dinitrofluorobenzene) RN - 0 (oligofructose) RN - 0 (Cytokines) RN - Kunming mice SB - IM MH - Mice MH - Female MH - Animals MH - *Dermatitis, Atopic/chemically induced/drug therapy/pathology MH - Dinitrofluorobenzene/adverse effects MH - Skin MH - Cytokines MH - Inflammation/drug therapy OTO - NOTNLM OT - atopic dermatitis OT - fructo-oligosaccharide OT - gut microbiota OT - gut-brain-skin axis OT - short-chain fatty acids EDAT- 2023/03/30 06:00 MHDA- 2023/06/08 06:42 CRDT- 2023/03/29 02:42 PHST- 2023/03/14 00:00 [revised] PHST- 2022/07/18 00:00 [received] PHST- 2023/03/28 00:00 [accepted] PHST- 2023/06/08 06:42 [medline] PHST- 2023/03/30 06:00 [pubmed] PHST- 2023/03/29 02:42 [entrez] AID - 10.1002/jsfa.12582 [doi] PST - ppublish SO - J Sci Food Agric. 2023 Aug 15;103(10):5004-5018. doi: 10.1002/jsfa.12582. Epub 2023 Apr 12.